How quickly do you feel Wegovy working — and what comes first?

Step 1, the first injection and the days that follow

The first thing most people notice is not dramatic. Wegovy's active ingredient, semaglutide, is a GLP-1 receptor agonist: it mimics a gut hormone that signals fullness to the brain and slows the rate at which the stomach empties. That mechanism begins from dose one, but the 0.25 mg starting dose is calibrated to let your body adjust, not to deliver maximum appetite suppression straightaway.

In those opening days, the signal tends to be quiet: meals that usually disappear feel like they stop being interesting halfway through. Some people barely register it; others find it striking. Nausea is the most commonly reported early experience, usually mild, usually worst in the 24–48 hours after an injection, and for most people it settles within a week or two. The NHS patient information for semaglutide sets out what to expect at each stage and is worth reading before your first pen arrives.

Weight on the scale at this point? Probably not much yet. That is completely normal. If you are curious about how quickly you feel the effects of Wegovy, the short answer is that the medicine is still finding its footing at this stage, and so are you.

Step 2 (weeks four to sixteen, as doses increase

Wegovy is prescribed on a titration schedule: 0.25 mg, then 0.5 mg, then 1.0 mg, then 1.7 mg, then 2.4 mg) roughly a new dose level every four weeks, paced by your prescriber. Each step tends to bring a clearer reduction in appetite, and this is typically when people start to see the scales move more consistently.

By weeks six to eight, many patients report that the pattern of eating has changed without much effort. Portions are smaller. The pull toward snacking between meals has weakened. Cravings (particularly for high-calorie foods) often reduce. This is the medicine working as intended. If you want a closer look at what the week-by-week trajectory looks like for most patients, our page on how quickly weight loss progresses on Wegovy covers the data in more detail.

Side effects can re-emerge briefly after each dose increase, then ease again. That ebb-and-flow pattern is what the titration schedule is designed to manage, a slower climb reduces the severity. Your prescriber and the Patient Information Leaflet are your guides on how to handle any particular symptom.

Step 3, the maintenance phase and what the evidence shows

Most patients reach the 2.4 mg maintenance dose somewhere around week sixteen to twenty. This is the dose used in the large STEP 1 clinical trial, where participants achieved an average body-weight reduction of around 15% over 68 weeks, a figure published in the New England Journal of Medicine and the basis for NICE's recommendation of Wegovy for eligible adults. For context on where those eligibility thresholds sit in the UK, the Wegovy overview page walks through the licence criteria.

By the maintenance phase, the felt effects are at their most consistent. Hunger is lower as a background state. Weight loss, when it happens, tends to be steadiest in the months spanning weeks twelve to forty or so, then slows as the body reaches a new equilibrium. That slowing is not failure, it is biology, and it is expected.

It is worth knowing that the 2024 approval of a 7.2 mg dose (with a dedicated single-dose pen approved by the MHRA in April 2026) has extended what is possible for some patients; your prescriber would discuss whether that step is clinically appropriate at the right point. For a fuller picture of how quickly results typically materialise, the Wegovy timeline page goes deeper on what the trial evidence actually shows at each phase.

A realistic word on variation

The honest answer to "how quickly will I feel it" is: it depends. People on the same dose at the same stage report quite different experiences. Metabolic rate, starting weight, diet, activity, sleep, stress, all of it shapes how the medicine is felt and how fast the numbers move. Some patients feel a meaningful appetite shift from week one; others are well into dose escalation before it clicks. Neither experience is wrong.

What the evidence is consistent on is that results build over months, not days, and that the biggest gains tend to come to people who stay on treatment long enough to reach and maintain the full dose. If you are weighing up whether the timeline fits your situation, what Wegovy results look like in practice might be a useful read alongside this page.

One thing our prescribers hear regularly: people who expected dramatic early results and nearly stopped before the medicine had time to work. If that is where you are right now (impatient, uncertain whether it is doing anything) that frustration is understandable, and it is a conversation worth having with a clinician rather than a reason to stop. You can also find a broader picture of costs and timelines, including private prescription routes, on the Wegovy cost page. When you are ready to take the next step, speak to our prescribers about whether Wegovy is the right fit for you.